Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 141 No. 5152 (2011)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system

  • C Wang
  • X Liu
  • Y Tang
  • H Peng
  • ZC Ye
  • J Zhang
  • H Tang
  • T Lou
DOI
https://doi.org/10.4414/smw.2011.13304
Cite this as:
Swiss Med Wkly. 2011;141:w13304
Published
19.12.2011

Summary

BACKGROUND: Podocyte injury plays an important role in glomerulosclerosis in IgA nephropathy (IgAN), and detachment from the glomerular basement membrane is the main cause of podocyte damage. In a previous study we found that medium from mesangial cells incubated with aggregated IgA1 (aIgA1) isolated from IgAN patients decreased podocyte adhesive capacity. However, the underlying mechanism remains unclear.

MATERIALS AND METHODS:Podocytes were incubated in medium from mesangial cells incubated with aIgA1 isolated from IgAN patients, enalaprilat (10–5 M) and chymostatin (20 μM), or with enalaprilat and chymostatin separately. Podocyte adhesive capacity was evaluated by cell counting and hexosaminidase assay. Expression of the renin angiotensin system was measured by real-time PCR, Western blot analysis and ELISA.

RESULTS: Angiotensinogen, renin and angiotensin II type 1 and 2 receptors mRNA and protein expression, angiotensin-converting enzyme activity, and angiotensin II levels increased in podocyte lysates and conditioned culture media on exposure to mesangial medium containing aIgA1 from IgAN patients (P<0.05). Enalaprilat or chymostatin partly improved the reduced adhesive capacity of podocytes compared to cells exposed to mesangial medium (P<0.05), but it was still lower than for podocytes exposed to mesangial medium containing aIgA1 from healthy controls (P<0.05).

CONCLUSION: Our findings indicate that activation of the renin angiotensin system in podocytes is partly involved in downregulation of adhesive capacity in podocytes by mesangial medium in IgA nephropathy.

References

  1. Li Ls, Liu Zh. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int. 2004;66:920–3.
  2. Nartia I, Gejyo F. Pathogenetic significance of aberrant glycosylation of IgA1 in IgA nephropathy. Clin Exp Nephrol. 2008;12:332–8.
  3. van der Boog PJ, van Kooten C, de Fijter JW, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005;67:813–21.
  4. Ding Jx, Xu Lx, Lv Jc, Zhao Mh, Zhang H, Wang Hy. Aberrant sialylation of serum IgA1 was associated with prognosis of patients with IgA nephropathy. Clin Immunol. 2007;125:268–74.
  5. Peng Ai, Gu Y, Xiao T, Zhu Ky, Zhang M, Yang Hc, et al. Clinicopathological characteristics of IgA nephropathy with urinary podocyte excretion. Chin J Nephrol. 2007;23:283–5.
  6. Shanklang SJ. The podocyte’s response to injury: role in proteinuria and glomerulosclerosis. Kidney Int. 2006;69:2131–47.
  7. Arant T. Petermann, Ron Krofft, Mary Blonski, et al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int. 2003,64:1222–31.
  8. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol. 2002;13:3005–15.
  9. Steanie U. Vogelmann, W. James Nelson, Bryan D. Myers, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol. 2003,285:F40-48.
  10. Ye Z, Wang C, Tang Y, et al. Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways. Clin Invest Med. 2009;32:E20-7.
  11. Wang C, Liu X, Ye Z,Zhang J, Tang H, Chen Z, Zhang H, Lou T. Mesangial medium with IgA1 from IgA nephropathy inhibit nephrin expression in podocytes Eur J Clin Invest. 2009;39:561–7.
  12. Landegren U. Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods. 1984;67:379–88.
  13. Cushman DW, Cheung HS. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol. 1971;20:1637–48.
  14. Jennings DL, Kalus JS, Coleman CL, et al. Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis. Diabet Med. 2007;24:486–93.
  15. Max CL, Lang D, Bohm J, et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol. 2006;290:F710–F719.
  16. Yadav A, Vallbu S, Arora S, et al. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol. 2010;299:C488–96.
  17. Hsu HH, Hoffmann S, Endlich N, et al. Mechanisms of angiotensin II signaling on cytoskeleton of podocytes. 2008;86:1379–94.
  18. Sungmi P, Benjamin JB, Hiroyuki K, et al. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol. 2010;298:F37–48
  19. Koichi S, Gi DH, Naoko M, et al. Angiotensin II Type 1 and Type 2 Receptors Play Opposite Roles in Regulating the Barrier Function of Kidney Glomerular Capillary Wall. Am J Pathol. 2007;170:1841–53.
  20. Wang Ch, Peng H, Tang H, et al. Serum IgA1 from IgA nephropathy induces apoptosis in podocytes through direct and indirect pathway. Clin Invest Med. 2007;30:E240–9.
  21. Wang Y, Zhao MH, Zhang YK, et al. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin Exp Immunol. 2004;136:168–75.
  22. Wang Y, Zhao MH, Zhang Y, et al. Serum IgA(1) from patients with IgA nephropathy induces phosphorylation of extracellular signal-regulated kinase and proliferation of human mesangial cells. Zhonghua Yi Xue Za Zhi. 2002;82:1406–9.
  23. Cecile D, Marc OB, Anthea H, et al. Mechanical forces and TGFβ1 reduce podocyte adhesion through α3β1 integrin downregulation. Nephrol Dial Transplant. 2009;24:2645–55.